Skip to content

Feasibility Study: Lifting and Tightening of the Elbows

Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening of the Elbow Tissue - A Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01708382
Enrollment
21
Registered
2012-10-17
Start date
2011-09-30
Completion date
2013-02-28
Last updated
2017-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Laxity

Keywords

Ulthera® System, Ultherapy™ Treatment, Ulthera, Inc., Ultrasound treatment for skin tightening

Brief summary

Up to 20 subjects will be treated. Treated subjects will receive one Ulthera® treatment on the elbows. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

Detailed description

This is a prospective, single-center, pilot clinical trial to evaluate the efficacy of the Ulthera® System to improve skin laxity above the elbows. Masked assessment of pre- and post-treatment photos will be performed. Global Aesthetic Improvement Scale scores and patient satisfaction questionnaires will also be obtained.

Interventions

Focused ultrasound energy delivered below the surface of the skin

Sponsors

Ulthera, Inc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female, age 21 to 65 years. * Subject in good health. * Mild to moderate skin laxity on the elbows. * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period. * Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study. * Subjects of childbearing potential must have a negative urine pregnancy test result and must not be lactating at Visit 1 and be willing and able to use an acceptable method of birth control

Exclusion criteria

* Presence of an active systemic or local skin disease that may affect wound healing. * Excessive subcutaneous fat around the elbows. * Excessive skin laxity around the elbows. * Significant scarring in areas to be treated. * Significant open wounds or lesions in the area to be treated

Design outcomes

Primary

MeasureTime frameDescription
Overall improvement of skin laxity in the areas treated90 days post-treatmentDetermined by masked assessment analysis of photographs at 90 days post treatment compared to baseline.

Secondary

MeasureTime frameDescription
Aesthetic improvement90 and 180 days post-treatmentGAIS scores will be obtained by the Investigator and subjects at all visits excluding baseline. Additionally, subject satisfaction questionnaires will also be obtained.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026